Top compounds associated with response to ARHGEF7


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.048 0.3
mRNA tivozanib CTRPv2 pan-cancer AAC -0.054 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC -0.003 0.9
mRNA tosedostat CTRPv2 pan-cancer AAC 0.085 0.03
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.046 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.041 0.2
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.081 0.05
mRNA triptolide CTRPv2 pan-cancer AAC -0.051 0.2
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.11 0.0008
Download CSV